Less invasive diagnostic testing based on elevated levels of prostate-specific antigen (PSA) can identify up to 60% of cases of early prostate cancer, although the test gives false negative results in approximately 30% of patients because of its relatively low specificity 11, 12. The gene discussed is KLK3; the disease is Familial prostate cancer.